Idursulfase

From Wikipedia, the free encyclopedia
  (Redirected from Elaprase)
Jump to: navigation, search
Idursulfase
Clinical data
AHFS/Drugs.com Monograph
ATC code
Identifiers
CAS Number
DrugBank
ChemSpider
  • none
UNII
KEGG
ChEMBL
 NYesY (what is this?)  (verify)

Idursulfase (brand name Elaprase), manufactured by Shire, is a drug used to treat Hunter syndrome (also called MPS-II).[1] It is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line.

It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.[2][3][4]

References[edit]

  1. ^ Garcia AR, DaCosta JM, Pan J, Muenzer J, Lamsa JC (2007). "Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II". Mol. Genet. Metab. 91 (2): 183–90. PMID 17459751. doi:10.1016/j.ymgme.2007.03.003. 
  2. ^ "Drug approved to treat rare but potentially deadly disease". Retrieved 2011-04-29. 
  3. ^ Health Care: The World's Most Expensive Drugs, Matthew Herper, Forbes, Feb. 22, 2010
  4. ^ [1], Barbara Kollmeyer, Marketwatch, Fed. 3, 2016

External links[edit]